[HTML][HTML] Caplacizumab for immune thrombotic thrombocytopenic purpura: real-world multicenter data

…, A Mpanti, C Pontikoglou, C Kalpadaki… - Frontiers in …, 2023 - frontiersin.org
Given the limited real-world data of caplacizumab, our multicenter real-world study was
designed to assess the safety and efficacy of caplacizumab in immune thrombotic …

[HTML][HTML] Impaired mRNA expression of the migration related chemokine receptor CXCR4 in mesenchymal stem cells of COPD patients

…, E Tsitoura, I Lasithiotaki, C Kalpadaki… - International Journal of …, 2017 - hindawi.com
Defective tissue repair and remodeling are main aspects of Chronic Obstructive Pulmonary
Disease (COPD) pathophysiology. Bone marrow mesenchymal stem cells (BM-MSCs) have …

[HTML][HTML] Real-world data of thrombotic microangiopathy management: The key role of ADAMTS13 activity and complement testing

…, EE Koravou, T Chatziconstantinou, C Kalpadaki… - Thrombosis …, 2021 - Elsevier
ADAMTS13 (A Disintegrin and Metalloprotease with ThromboSpondin type 1 motifs) activity
is a key tool in differential diagnosis of thrombotic microangiopathies (TMAs). Due to the lack …

Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative …

…, P Mitsikostas, C Kalpadaki… - European journal of …, 2012 - Springer
Combination antimicrobial therapy represents common practice in the treatment of febrile
neutropenia aiming to broaden the antimicrobial spectrum against Gram-negative pathogens. …

Rituximab-CHOP (R-CHOP) and Radiotherapy (RT) for Primary Mediastinal Large B-Cell Lymphoma (PMLBCL).

…, MP Siakantaris, FN Kontopidou, C Kalpadaki… - 2006 - ashpublications.org
Background: MACOP-B or even chemotherapy (CT) with consolidation high dose therapy
with autologous stem cell support (HDT-ASCT) have been considered superior to CHOP in …

Serum Soluble Syndecan-1 Levels Correlate with Erythropoietin and Inversely with Hemoglobin Levels in Untreated Anaemic Myeloma Patients: Possible Role of …

…, E Dimitriadou, MK Angelopoulou, C Kalpadaki… - Blood, 2004 - Elsevier
Impaired erythropoiesis with inappropriate erythropoietin (EPO) production is seen in about
40% of symptomatic multiple myeloma (MM) patients at diagnosis and worsens during …

ELEVATED PLATELET REACTIVITY IN PATIENTS WITH UNCONTROLLED HYPERTENSION: THE EFFECT OF CHA2DS2-VASC SCORE

…, S Maragkoudakis, C Kalpadaki… - Journal of …, 2023 - journals.lww.com
Objective: Hypertension is associated with vascular and endothelial dysfunction that may
result in a greater propensity for reactive platelets to cause thrombosis. Purpose: The aim of …

[HTML][HTML] P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE …

…, A Symeonidis, A Piperidou, C Kalpadaki… - …, 2022 - journals.lww.com
Background: Real-life studies of moderate size have shown satisfactory but less impressive
results compared with the initial study of R-da-EPOCH in PMLBCL. However, the strategies …

[HTML][HTML] Topoisomerase IIα (TopoIIα) Expression in Hodgkin's Lymphoma (HL): Correlations with Conventional and Biological Markers and Prognostic Significance …

…, EM Dimitriadou, MN Dimopoulou, C Kalpadaki… - Blood, 2005 - Elsevier
TopoIIα is a proliferation marker, as well as a target for cytotoxic agents used in HL, such as
doxorubicine, epirubicine, etoposide, and mitoxantrone. High topoIIα expression has been …

Elevated platelet reactivity in patients with uncontrolled hypertension: the effect of CHA2DS2-VASc score

…, I Anastasiou, N Androulakis, C Kalpadaki… - European Heart …, 2022 - academic.oup.com
Background Hypertension is associated with vascular and endothelial dysfunction that may
result in a greater propensity for reactive platelets to cause thrombosis. Purpose The aim of …